KIM JULIE SO-YOUNG (CEO - Elect) sold 18.5% of their position (89.09K shares) of TAKEDA PHARMACEUTICAL CO LTD on the open market
Open‑market sale worth $1.52M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2026ACC: 0001493152-26-037484
Officer· CEO - Elect
Since Mar 2026
-89.09K
Net shares
Net seller
$1.52M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
89.09K disposed
Non-Derivative Transactions1
American Depositary Shares
Direct
Shares
−89.09K
Price / share
$17.10
Trade value
$1.52M
% of position
18.5%
8/10/2026
480.58K→391.49K
Total
Net shares
−89.09K
Net value
-$1.52M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 8/10/2026 | S · Sale | −89.09K | $17.10 | $1.52M | 18.5% | 480.58K | 391.49K |
| Total | −89.09K | -$1.52M | ||||||
Derivative Transactions0
No derivative transactions reported